Patients with cancer are frequently anaemic, with contributing factors including chemotherapy and the anaemia of chronic disease, with endogenous erythropoietin deficiency, relative erythropoietin resistance, and shortened red cell survival (Miller et al, 1990). Here, EPO is linked to hyperinsulinemic hypoglycemia, familial, 4.